
Nymox Pharmaceutical Corporation NYMX
Geschäftsbericht 2024
hinzugefügt 25.04.2026
Nymox Pharmaceutical Corporation DSO 2011-2026 | NYMX
DSO Jährlich Nymox Pharmaceutical Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 12.5 | 36.8 | 83.6 | 63.1 | 73.3 | 46.1 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 83.6 | 12.5 | 52.6 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
2.94 K | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
29 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Coherus BioSciences
CHRS
|
559 | $ 1.63 | -4.4 % | $ 191 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 7.83 | -5.21 % | $ 214 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.12 | - | $ 649 M | ||
|
Exelixis
EXEL
|
43.4 | $ 51.1 | -0.37 % | $ 13.9 B | ||
|
Karyopharm Therapeutics
KPTI
|
71.1 | $ 8.9 | 0.56 % | $ 1.08 M | ||
|
AbCellera Biologics
ABCL
|
173 | $ 4.4 | -7.76 % | $ 1.31 B | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
70.9 | $ 17.3 | -5.57 % | $ 809 M | ||
|
Compugen Ltd.
CGEN
|
60.8 | $ 3.03 | 6.32 % | $ 283 M | ||
|
Gilead Sciences
GILD
|
57.8 | $ 132.06 | -0.74 % | $ 164 B | ||
|
Genmab A/S
GMAB
|
97.9 | $ 26.9 | 1.32 % | $ 1.74 B | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 3.49 | -4.12 % | $ 5.75 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Fortress Biotech
FBIO
|
115 | $ 2.3 | 3.14 % | $ 64.2 M | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
106 | $ 21.57 | -0.55 % | $ 2.74 B | ||
|
Fennec Pharmaceuticals
FENC
|
148 | $ 9.24 | 36.48 % | $ 264 M |